Taipei, Taiwan

Yi-Zhou Chen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Taipei Medical University. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi-Zhou Chen. Retrieved from https://idiyas.com/inventor/yi-zhou-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yi-Zhou Chen: Innovator in Ophthalmic Composition

Introduction

Yi-Zhou Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of ophthalmology, particularly in developing innovative solutions for eye care. His work focuses on addressing common eye conditions, such as dry eye syndrome.

Latest Patents

Yi-Zhou Chen holds a patent for a lutein-containing ophthalmic composition. This composition is designed to include a natural anti-inflammatory substance, a substance that increases liquid viscosity, and an artificial tear. The formulation aims to enhance the retention time of the anti-inflammatory substance on the ocular surface, thereby providing relief for individuals suffering from dry eye syndrome and inhibiting ocular surface inflammation. He has 1 patent to his name.

Career Highlights

Yi-Zhou Chen is affiliated with Taipei Medical University, where he continues to engage in research and development in the field of ophthalmology. His work is characterized by a commitment to improving patient outcomes through innovative medical solutions.

Collaborations

He has collaborated with notable colleagues, including Ching-Li Tseng and I-Chan Lin, to further advance research in ophthalmic compositions.

Conclusion

Yi-Zhou Chen's contributions to ophthalmology through his innovative patent demonstrate his dedication to enhancing eye care. His work continues to impact the field positively, providing new solutions for those affected by eye conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…